Difference between revisions of "Topiramate"
From Psychiatrienet
(Created page with '{{Drug | name = topiramate | group = anticonvulsant | type = Moodstabilizer | medscape = 14496 | pubchem = 5284627 | drugscom = topiramate | ftk = topiramaat | ATC = N03AX11 | ad...') |
|||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Drug | {{Drug | ||
| − | | name = | + | | name = Topiramate |
| group = anticonvulsant | | group = anticonvulsant | ||
| − | | type = | + | | type = moodstabilizer |
| medscape = 14496 | | medscape = 14496 | ||
| pubchem = 5284627 | | pubchem = 5284627 | ||
| Line 8: | Line 8: | ||
| ftk = topiramaat | | ftk = topiramaat | ||
| ATC = N03AX11 | | ATC = N03AX11 | ||
| − | | | + | | metabolization = * Topiramate induces CYP3A4 and is an inhibitor of CYP2C19. |
| − | | | + | | administration = O |
| halflife = 21 | | halflife = 21 | ||
| halflife_ref = <ref name="ftk">{{FTK|topiramaat}}</ref> | | halflife_ref = <ref name="ftk">{{FTK|topiramaat}}</ref> | ||
| − | |||
| − | |||
| − | |||
| bioavailability = 50 | | bioavailability = 50 | ||
| bioavailability_ref = <ref name="ftk">{{FTK|topiramaat}}</ref> | | bioavailability_ref = <ref name="ftk">{{FTK|topiramaat}}</ref> | ||
| − | <includeonly> | + | | <includeonly> isswitch = 1 </includeonly> |
| − | |||
| − | </includeonly> | ||
}} | }} | ||
Latest revision as of 01:02, 27 April 2010
| Topiramate | |||||||||
| Type | moodstabilizer | ||||||||
| Group | anticonvulsant | ||||||||
| links | |||||||||
| ATC-code | N03AX11 | ||||||||
| PubChem | 5284627 | ||||||||
| PubMed | Topiramate | ||||||||
| Drugs.com | topiramate | ||||||||
| Kompas (Dutch) | Topiramate | ||||||||
| Wikipedia | Topiramate | ||||||||
| |||||||||
Topiramate is a moodstabilizer in the group anticonvulsant.
- Metabolization
- Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
